Nice paper (submission 122) and great share. Big pharma,,,IMO is going to kill AC8.
This process is set up for a reason and that is to run small companies like AC8 out of cashflow....which you need to compete as a player in the pharmaceutical space.
Hopefully (hope is not a strategy) that a politician will stand up and fight this purposely constructed bureaucracy to keep big pharma shielded and safe. This is not a good for AC8 share price and this paper is a cry for help against the system...hopefully (there is that word again..hope) it will drive this required change to allow AC8 to have chance and be competitive. Up hill battle...IMO.
Interested to hear others opinions on how they view submission 122...
- Forums
- ASX - By Stock
- AC8
- Ann: AusCann Releases Low-dose Form Capsule
Ann: AusCann Releases Low-dose Form Capsule, page-38
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AC8 (ASX) to my watchlist
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.62M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AC8 (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online